Biotech

All Articles

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of team

.Vir Medical's second-quarter incomes report wasn't short of big headlines. The firm invited a triad...

Galapagos pauses CAR-T tissue treatment litigation over Parkinsonism case

.Galapagos has actually stopped enrollment in a test of a BCMA-directed CAR-T tissue therapy, pumpin...

James Wilson leaving Penn to release 2 brand new biotechs

.After greater than thirty years, gene therapy trailblazer James Wilson M.D., Ph.D., is leaving the ...

3 biotechs attempt to trump the summer warm by shedding staff

.As biotechs try to switch a new webpage in August, at the very least 3 providers have dropped staff...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Expert financial backing agency venBio has actually raised another half a billion dollars to purcha...

Otsuka spends $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Therapeutics for $800 thousand so the...

FibroGen gives up 75% people personnel as asset flunks 2 even more tests

.FibroGen is substantially restructuring its organization, giving up 75% of its U.S. team and also c...

Tracon relax weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has actually determined to unwind procedures weeks after an injectable immun...

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on fallen short epilepsy medication, promotes FDA manage

.Our company currently know that Takeda is actually expecting to locate a course to the FDA for epil...